To facilitate opportunities for collaborative research and exchanges, KI participates in a number of networks.
International Network Medicine Consortium
More information on the International Network Medicine Consortium:
In the past year, the Brigham and Women’s Hospital / Harvard University and the Karolinska Institutet along with other Universities of Europe such as La Sapienza University, Maastricht University and Technical University of Vienna, have started working together as an International Network Medicine Consortium. After a start-up meeting in Rome autumn 2018, planning groups have been formed and activities currently being explored include: exchange of faculty and staff members, graduate and undergraduate students; joint grant applications, joint implementation of research projects, and much more.
More information on Network Medicine:
Network Medicine allows for the systematic exploration of the molecular complexity of a particular disease and also of the molecular relationships among apparently distinct pathologic phenotypes. The multidisciplinary expertise within the International Network Medicine Consortium (data analysts, mathematicians, physicists, medical researchers and clinicians) facilitates joint progress by using network theory to measure on a microscopic scale the relation between genes, proteins, endogenous and exogenous metabolites and diseases. On a larger scale the framework of multilevel networks will measure the likelihood and possible strength of side effects in patient treatment. Finally, on a macroscopic scale, data analysts can use network theory to assess quantitatively risky patient behavior. All these approaches are a powerful pillar in establishing diagnosis, risk prediction and treatment on an individual basis.
To inaugurate the initiative between the Brigham and Women’s Hospital / Harvard University and Karolinska Institutet within the International Network Medicine Consortium, KI hosts a symposium May 22, 2019 with top scientists in the field who will present their latest research and projects. The aim of the symposium is to promote the use of network science in personalized medicine and to present a new roadmap for personalized medicine research within clinical science.
Karolinska Institutet is a member of Eurolife. This network of nine prestigious European universities, aims to promote and facilitate collaborative research and education activities, the exchange of researchers, research students and master students and the creation of new research opportunities within the field of Life Sciences (Biomedicine and Medicine).
The Eurolife member institutions are: Universitat de Barcelona, Trinity College Dublin, The University of Edinburgh, University Medical Center Göttingen, Medical University of Innsbruck, Leiden University Medical Center, University of Strasbourg, Semmelweis University and Karolinska Institutet.
Scholars at Risk
KI is a member of Scholars at Risk Network (SAR). It is an international network of higher education institutions dedicated to protecting threatened scholars, preventing attacks on higher education communities and promoting academic freedom worldwide.
KI signed the Magna Charta Universitatum 2015. It contains principles of academic freedom and institutional autonomy as a guideline for good governance and self-understanding of universities in the future.